Dynavax (DVAX) Misses Q3 EPS by 15c

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.90), $0.15 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $162 thousand versus the consensus estimate of $2.44 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Goldman Sachs Downgrades Shanghai Jahwa United (600315:CH) to Neutral
• Deere shares climb as fiscal Q3 earnings and revenue top estimates